KAVI-Institute of Clinical Research, University of Nairobi, recently had the pleasure of hosting distinguished guests from the University of Gothenburg for an enriching scientific and academic engagement focused on biomedical sciences, student exchange opportunities, and international collaboration.
The recombinant protein production training workshop hosted by KAVI-Institute of Clinical Research in collaboration with BioStruct-Africa has officially commenced today at the University of Nairobi. Taking place at the Faculty of Health Sciences in Nairobi from 27 April to 2 May 2026, the week-long workshop brings together a select group of scientists for an intensive, hands-on learning experience focused on recombinant protein production.
KAVI-Institute of Clinical Research (KAVI-ICR), University of Nairobi, recently hosted a high-level delegation from Sanofi for an engaging visit to discuss potential pathways of collaboration and showcase the institute’s robust research capabilities across the continent.
The KAVI-Institute of Clinical Research, in collaboration with BioStruct-Africa, will host a week-long hands-on training workshop focused on recombinant protein production as a strategic tool for strengthening vaccine manufacturing capacity in Africa.
On Friday, 17th April 2026, KAVI-ICR had the privilege of hosting Dr Dipesh Solanky, MD, for a guest seminar titled:
“Molecular Diagnostics for HPV and the Role of Amplicon Sequencing toward Cervical Cancer Elimination.”
This week, KAVI–Institute of Clinical Research (KAVI-ICR), University of Nairobi, in partnership with ClinWin Research Services, is hosting a high-impact Clinical Trial Monitoring Course in Nairobi, bringing together early-career and experienced professionals from across the region. The course is part of a long-standing collaboration between KAVI-ICR and ClinWin focused on strengthening Africa’s clinical research ecosystem through practical, skills-based training and mentorship.
KAVI-Institute of Clinical Research (KAVI-ICR) continues to demonstrate leadership in laboratory biosafety and biosecurity through its participation in the CEPI ISO 35001 Implementation Project. Representatives from KAVI-ICR, including its founder, Professor Omu Anzala, and Laboratory Technologist Dennis Chalo, attended a high-level coordination meeting at the National Institute for Communicable Diseases in Johannesburg from March 30 to April 1, 2026.
KAVI-Institute of Clinical Research is proud to highlight the participation of our Postdoctoral Research Fellow, Dr Zipporah Richard, in the One Health Early Career Champions Programme held in Helsinki, Finland.
The KAVI-Institute of Clinical Research (KAVI-ICR) recently visited the Microsoft AI for Good Lab in Nairobi. The meeting provided an opportunity to exchange ideas at the intersection of artificial intelligence and public health research and to understand each other’s work better.
KAVI-ICR hosted Dr Huwaida Bulhan, Africa Region Lead at Sanofi, for a courtesy visit focused on strengthening academia–industry collaboration.
